Sale!

NAFLD – PNPLA3 and TM6SF2 Genotyping Test Cost

Original price was: 910 د.إ.Current price is: 820 د.إ.

-10%

The NAFLD – PNPLA3 and TM6SF2 Genotyping Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to assess an individual’s genetic predisposition to Non-Alcoholic Fatty Liver Disease (NAFLD). This condition, characterized by excessive fat buildup in the liver not caused by alcohol use, is a growing health concern globally. The test specifically looks for variations in the PNPLA3 and TM6SF2 genes, which have been identified as significant genetic markers associated with the risk and progression of NAFLD.

By analyzing a sample of the patient’s DNA, the test can identify specific mutations in these genes that may indicate a higher likelihood of developing NAFLD, thus allowing for early intervention and personalized treatment plans. This proactive approach can be crucial in managing the condition effectively, preventing its progression to more severe liver diseases such as non-alcoholic steatohepatitis (NASH), cirrhosis, or liver cancer.

Offered at a cost of 820 AED, the NAFLD – PNPLA3 and TM6SF2 Genotyping Test is an investment in personalized healthcare, enabling individuals to take informed steps towards managing their liver health based on their genetic makeup. It underscores the growing importance of genetic testing in the prevention and management of chronic diseases, offering a tailored approach to healthcare in the UAE.

Description

NAFLD – PNPLA3 and TM6SF2 GENOTYPING Test

Test Name: NAFLD – PNPLA3 and TM6SF2 GENOTYPING Test

Components:

PNPLA3
TM6SF2

Price: 820.0 AED

Sample Condition: 3 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Report Delivery: Sample Mon / Thu by 9 am; Report Wed / Sat

Method: Real time PCR

Test Type: Disorders of Liver

Doctor: Gastroenterologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Test Details:

The NAFLD (non-alcoholic fatty liver disease) PNPLA3 and TM6SF2 genotyping test is a genetic test that analyzes specific gene variants in the PNPLA3 and TM6SF2 genes. These gene variants have been associated with an increased risk of developing NAFLD.

PNPLA3 and TM6SF2 are genes involved in lipid metabolism and are believed to play a role in the development and progression of NAFLD. Variants in these genes can affect the way the liver processes and stores fat, leading to an accumulation of fat in the liver and potentially causing liver damage.

The genotyping test for PNPLA3 and TM6SF2 involves analyzing a person’s DNA sample to determine their specific gene variants in these genes. This information can help identify individuals who may be at a higher risk of developing NAFLD or experiencing more severe liver disease.

By identifying individuals with high-risk gene variants, healthcare providers can provide personalized recommendations for lifestyle modifications, such as dietary changes and increased physical activity, to reduce the risk of developing NAFLD or to manage the condition more effectively.

It’s important to note that while the PNPLA3 and TM6SF2 gene variants are associated with an increased risk of NAFLD, they are not the sole determinants of the disease. Other genetic and environmental factors also contribute to the development and progression of NAFLD.

Test Name	NAFLD – PNPLA3 and TM6SF2 GENOTYPING Test
Components	PNPLA3 TM6SF2
Price	820.0 AED
Sample Condition	3 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery	Sample Mon / Thu by 9 am; Report Wed / Sat
Method	Real time PCR
Test type	Disorders of Liver
Doctor	Gastroenterologist
Test Department:	MOLECULAR DIAGNOSTICS
Pre Test Information	Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Test Details	The NAFLD (non-alcoholic fatty liver disease) PNPLA3 and TM6SF2 genotyping test is a genetic test that analyzes specific gene variants in the PNPLA3 and TM6SF2 genes. These gene variants have been associated with an increased risk of developing NAFLD. PNPLA3 and TM6SF2 are genes involved in lipid metabolism and are believed to play a role in the development and progression of NAFLD. Variants in these genes can affect the way the liver processes and stores fat, leading to an accumulation of fat in the liver and potentially causing liver damage. The genotyping test for PNPLA3 and TM6SF2 involves analyzing a person’s DNA sample to determine their specific gene variants in these genes. This information can help identify individuals who may be at a higher risk of developing NAFLD or experiencing more severe liver disease. By identifying individuals with high-risk gene variants, healthcare providers can provide personalized recommendations for lifestyle modifications, such as dietary changes and increased physical activity, to reduce the risk of developing NAFLD or to manage the condition more effectively. It’s important to note that while the PNPLA3 and TM6SF2 gene variants are associated with an increased risk of NAFLD, they are not the sole determinants of the disease. Other genetic and environmental factors also contribute to the development and progression of NAFLD.